Goldman Sachs’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
WDC
BL
CM
FLPIM
GRP
Goldman Sachs's GNLX Position: Q2 2026 in Review
Goldman Sachs increased its Genelux (GNLX) stake by 40% in Q2 2026, buying an estimated $37.4K and bringing the position to 45,809 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #6292.
Goldman Sachs first reported a position in GNLX in Q1 2023 and has held it in 10 quarters since. The position peaked at $801K in Q4 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.
- Goldman Sachs held 45,809 shares of Genelux worth $138K as of Q2 2026.
- Goldman Sachs bought 13,199 Genelux shares in Q2 2026, an estimated $37.4K.
- Genelux made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6292 holding.
- Goldman Sachs first reported a position in Genelux in Q1 2023 and has held it in 10 quarters since.
- Goldman Sachs's Genelux position peaked at $801K in Q4 2025.
- 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.